Tyrian Diagnostics Overview

  • Year Founded
  • 1999

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 50

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $13M

Tyrian Diagnostics General Information

Description

Contango Asset Management Ltd is a wholesale and listed investment company fund manager. The company manages the large-cap, mid-cap, small-cap, micro-cap and income-focused mandates. It also manages three LIC mandates for NAOS Small Cap Opportunities Companies Ltd, Contango Income Generator Ltd and WCM Global Growth Ltd.

Contact Information

Formerly Known As
Proteome Systems
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • Locked Bag 2073
  • Post Box 1670
  • North Ryde, New South Wales 2113
  • Australia
Primary Industry
Diagnostic Equipment
Other Industries
Drug Discovery
Biotechnology
Vertical(s)
Corporate Office
  • Locked Bag 2073
  • Post Box 1670
  • North Ryde, New South Wales 2113
  • Australia

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Tyrian Diagnostics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Merger/Acquisition 24-Jun-2016 $13M Completed Generating Revenue
5. PIPE 25-Aug-2008 Completed Generating Revenue
4. PIPE 08-Sep-2005 Completed Generating Revenue
3. IPO 30-Sep-2004 Completed Generating Revenue
2. Grant 26-Sep-2000 $1.84M $9.1M Completed Startup
1. Early Stage VC 26-Sep-2000 $9.1M $9.1M Completed Startup
To view Tyrian Diagnostics’s complete valuation and funding history, request access »

Tyrian Diagnostics Patents

Tyrian Diagnostics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2011901684-A0 Method of diagnosis of infection by mycobacteria and reagents therefor Inactive 06-May-2011
AU-2011901686-A0 Method of diagnosis of infection by mycobacteria and reagents therefor Inactive 06-May-2011
AU-2011901688-A0 Method of diagnosis of infection by mycobacteria and reagents therefor Inactive 06-May-2011
AU-2011901691-A0 Method of diagnosis of infection by mycobacteria and reagents therefor Inactive 06-May-2011
AU-2011901704-A0 Method of diagnosis of infection by mycobacteria and reagents therefor Inactive 06-May-2011
To view Tyrian Diagnostics’s complete patent history, request access »

Tyrian Diagnostics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Tyrian Diagnostics Former Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
BTC Health Venture Capital Minority
Challenger Asset Manager Minority
Government of Australia Government
OppenheimerFunds Asset Manager Minority
QIC Sovereign Wealth Fund Minority
To view Tyrian Diagnostics’s complete investors history, request access »

Tyrian Diagnostics Investments (1)

Tyrian Diagnostics’s most recent deal was a Joint Venture with Charles River Proteomic Services for . The deal was made on 02-Oct-2002.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Charles River Proteomic Services 02-Oct-2002 Joint Venture Laboratory Services (Healthcare)
To view Tyrian Diagnostics’s complete investments history, request access »

Tyrian Diagnostics FAQs

  • When was Tyrian Diagnostics founded?

    Tyrian Diagnostics was founded in 1999.

  • Where is Tyrian Diagnostics headquartered?

    Tyrian Diagnostics is headquartered in North Ryde, Australia.

  • What is the size of Tyrian Diagnostics?

    Tyrian Diagnostics has 50 total employees.

  • What industry is Tyrian Diagnostics in?

    Tyrian Diagnostics’s primary industry is Diagnostic Equipment.

  • Is Tyrian Diagnostics a private or public company?

    Tyrian Diagnostics is a Private company.

  • What is the current valuation of Tyrian Diagnostics?

    The current valuation of Tyrian Diagnostics is .

  • What is Tyrian Diagnostics’s current revenue?

    The current revenue for Tyrian Diagnostics is .

  • How much funding has Tyrian Diagnostics raised over time?

    Tyrian Diagnostics has raised $41.1M.

  • Who are Tyrian Diagnostics’s investors?

    BTC Health, Challenger, Government of Australia, OppenheimerFunds, and QIC have invested in Tyrian Diagnostics.

  • When was Tyrian Diagnostics acquired?

    Tyrian Diagnostics was acquired on 24-Jun-2016.

  • Who acquired Tyrian Diagnostics?

    Tyrian Diagnostics was acquired by Associate Global Partners.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process